Missailidis, Sotiris published the artcileAntitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design, Computed Properties of 606-55-3, the publication is Oncology Research (2002), 13(3), 175-189, database is CAplus and MEDLINE.
The biophys. and biol. characterization of 8,13-diethyl-6-methylquino[4,3,2-k1]acridinium iodide (6) is reported. The compound binds to DNA, as measured by UV, fluorescence, and CD studies, and stabilizes the double helix and higher order DNA structures (DNA triplexes and quadruplexes) against thermal denaturation. Unlike many DNA ligands, (6) shows no specificity for binding to specific base pair combinations and does not inhibit topoisomerase I (topo I) or topo II activity. Furthermore, the biol. fingerprint elicited by (6) in in vitro evaluations does not compare with clin. agents of the topo II inhibition class. The compound provokes cell cycle arrest in response to DNA damage and the biol. sequelae are dependent on the p53 status of the cell line. DNA damage by (6) up-regulates p53 and p21CIP/WAF1 proteins. The unusual structure of (6) and its ease of synthesis in a one-pot reaction are features that are being exploited in the design and development of a new series of G-quadruplex stabilizing telomerase inhibitors. However, although the second-generation compounds that resulted from (6) present strong telomerase inhibition, (6) in itself presents yet a different mode of action, with a strong preference for triplex DNA, sequences often found in a number of genes.
Oncology Research published new progress about 606-55-3. 606-55-3 belongs to iodides-buliding-blocks, auxiliary class Quinoline,Salt, name is 1-Ethyl-2-methylquinolin-1-ium iodide, and the molecular formula is C12H14IN, Computed Properties of 606-55-3.
Referemce:
https://en.wikipedia.org/wiki/Iodide,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com